Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice
Crossref DOI link: https://doi.org/10.1007/s00520-015-3039-4
Published Online: 2015-12-15
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Weycker, Derek
Li, Xiaoyan
Barron, Rich
Li, Yanli
Reiner, Maureen
Kartashov, Alex
Figueredo, Jacqueline
Tzivelekis, Spiros
Garcia, Jacob
Funding for this research was provided by:
Amgen
License valid from 2015-12-15